NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Maintains Positive Outlook for Radico Khaitan

Radico Khaitan, a leading spirits company, continued to demonstrate strong operating performance in the fourth quarter of fiscal year 2026 and the entire fiscal year 2026. The company reported a revenue growth of 15% year-over-year (YoY) at INR15.0 billion, with a significant increase in premium and above (P&A) value growth at 29%.

In contrast, the regular portfolio declined by 14% YoY. However, the P&A segment sustained its industry-leading performance, with volumes jumping 28% YoY to 4.4 million cases, exceeding the estimated 4.1 million cases. On the other hand, regular portfolio volumes declined 10% YoY to approximately 5 million cases due to a high base and the impact of policy changes in Karnataka and Maharashtra. Royalty cases declined 9% YoY to 0.4 million cases.

SegmentQ4 FY26/FY26 Revenue GrowthQ4 FY26/FY26 Volume Growth
P&A29%28%
Regular Portfolio-14%-10%
Royalty Cases-9%-9%

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Radico Khaitan's strong operating performance is reflected in its valuation multiples. The company is currently trading at 58x/47x FY27E/FY28E price-to-earnings (P/E) ratio, with a return on equity (RoE) and return on invested capital (RoIC) of 20% and 23% in FY27E, respectively. Motilal Oswal believes that the company's projected 25% earnings per share (EPS) compound annual growth rate (CAGR) over FY26-28E provides adequate support for sustaining rich valuations.

The research firm values Radico Khaitan at 55x P/E on March 2028 estimated EPS, resulting in a target price of INR4,000.

Investor Takeaway

Investors should consider Radico Khaitan for its robust P&A volume growth and strong operating performance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.